openPR Logo
Press release

curasan AG: New US subsidiary for orthopaedics

02-19-2010 10:39 AM CET | Health & Medicine

Press release from: curasan AG

Kleinostheim, Germany, 18th February 2010 – curasan AG, listed in the General Standard of the Deutsche Börse AG (ISIN: DE 000 549 453 8), is commencing the sale, through a subsidiary, of its synthetic bone regeneration material Cerasorb® M Ortho in the United States.

The newly founded curasan Inc., with its headquarters in Massachusetts, is responsible for commercial and logistical management as well as marketing activities. This occurs in coordination with the head office in Germany. The processing of orders and shipment is undertaken by specialist service providers, in order to avoid the need to staff such activities locally.

Local sales will occur through an external dealer network that specialises in targeting orthopaedists, trauma surgeons and spine surgeons. For some regions, sales contracts already exist; in the remaining states, the sales network will be expanded during the course of the year. Independent representatives and distributors experienced with these targeted customer groups and interested in pursuing this exciting opportunity are encouraged to contact the US office at office@curasan.com.

“Because we have already previously established and successfully disposed of a subsidiary in the US for the dental market, we are now benefiting from that experience”, stated Hans Dieter Rössler, CEO of curasan AG. “At almost US$ 1 billion, the market potential for bone regeneration materials in orthopaedics, trauma surgery and traumatology in the US is extremely attractive. Human bones from tissue banks form the largest proportion of this material; however, the share of synthetic bone replacement materials has clearly risen more sharply than the overall market in the last few years and is predicted to take over the market leadership within the next three years. The aim of our US activities is to participate at a manageable cost in this market development with the synthetic Cerasorb® M Ortho.”

From 9th - 13th March 2010, curasan Inc. will be occupying a trade fair stand during the American Academy of Orthopaedic Surgeons (AAOS) conference in New Orleans. This is the world’s largest event for orthopaedists and related healthcare experts.

Background information about curasan AG:
Exchange listed curasan AG (ISIN: DE 000 549 453 8) is one of the leading firms in the field of regenerative medicine especially in bone and tissue regeneration. In addition to the synthetic Cerasorb® bone substitution and regeneration material, the company has developed a future-oriented product pipeline. The goal during the next few years is to have further medical products ready for market rollout via well-positioned contractual partners in various market segments.

Press Contact:
curasan AG
Andrea Weidner
Lindigstrasse 4
63801 Kleinostheim
Germany
Tel. +49 (0)6027 40 900-51
Fax +49 (0)6027 40 900-39
andrea.weidner@curasan.de
www.curasan.de

fr financial relations gmbh
Jörn Gleisner
Tel. +49 (0)69 95 90 83 20
Fax +49 (0)69 95 90 83 99
j.gleisner@finanical-relations.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release curasan AG: New US subsidiary for orthopaedics here

News-ID: 121220 • Views:

More Releases from curasan AG

curasan AG: Dental Business Unit acquired as of June 1
Kleinostheim, Germany, June 6, 2013 – curasan AG, Germany, has acquired a large part of the “Oral Regenerative Medicine” division of Riemser Pharma GmbH, Germany, effective June 1, 2013. curasan AG now owns the marketing and distribution rights for the products covered by the contract and is assuming the sales structures, including the na-tional and international customer base. As a result of this change, curasan has immediate access to the dental market
curasan AG now sells bone regeneration material in injectable form
curasan AG now sells bone regeneration material in injectable form
Kleinostheim, 05.12.2012 – curasan AG, listed on the General Standard (ISIN: DE 000 549 453 8), has introduced its new bone regeneration material CERASORB® Ortho Paste to the German and European markets at the beginning of December. CERASORB® Ortho Paste is comprised of fine granules of the proven, fully resorbable, synthetic material CERASORB® M Ortho suspended in a hyaluronic acid hydrogel-matrix. The paste-like product has the advantage that it is
curasan AG commences operations in the European market with the appointment of a …
Kleinostheim, 15.02.2012 – curasan AG, listed in the General Standard (ISIN: DE 000 549 453 8), created a new post on 1st February 2012 in relation to the active expansion of its European sales network in the fields of Orthopaedics and trauma surgery. Mr. Lee McCann BSc Business Administration (North West University of Applied Science, London, U.K.), will be operating as the organisation’s International Sales Director for Orthobiologics with immediate
curasan AG: Novel bone regeneration material approved for sale in Europe
Kleinostheim, Germany – curasan AG, which is listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has received European approval for a novel synthetic bone regeneration material. Osseolive® is a bioactive, poly-crystalline calcium-alkali-phosphate ceramic, which has a stimulating effect on bone formation as well as on bone mineralisation. “With Osseolive® emerging from our well-stocked development pipeline, we now have an ideal extension to our tricalcium-phosphate

All 5 Releases


More Releases for Germany

Germany Agriculture Market, Germany Agriculture Industry, Germany Agriculture Da …
Agriculture is important sector for the Germany’s food security and also a provider of jobs. More than half of country’s national territory is used for farming. Approximately 1 million people currently work part-time or full-time in agricultural holdings. Key agricultural products include milk, cereals, potatoes, barley, cabbages, pork, beef, poultry, wheat, and sugar beets. In some regions fruits & vegetables, wine and other horticultural products play a significant role. Agricultural
High Voltage System Market 2020: Top Key Players Are Bosch (Germany), Continenta …
High Voltage System Market Overview: Research report on The High Voltage System Market by ‘Market Growth Insight’ covers deep analysis on key factors that directly influence the market growth including impact of COVID-19. The report is a thorough study of drivers, opportunities, restraints, challenges, and risks associated with the High Voltage System market to help the players plan their growth activities and strategies carefully, while considering these crucial factors. The High
Product Engineering Services Market Outlook 2024 By Key Players: Accenture PLC(G …
Product Engineering Services Market reports report offers a comprehensive evaluation of the global market analysis (2019-2024). This 94 pages research study involves the extensive use of both primary interviews and secondary research data sources. The report consists of market share, size, CAGR, industry analysis, go to market strategy, SWOT analysis, sales, revenue, key players, information on products and application, competitive insights, value chain, and macroeconomic analysis etc. The product engineering is
2019 Autonomous Luxury Vehicle Market | By Leading Players: Daimler (Germany), B …
Autonomous Luxury Vehicle Market report covers the data which is helpful for key players, product scope, market overview, market opportunities, market risk, market driving force, technological advancement, distributors, traders, dealers, research findings. These data representations provide predictive data regarding the future estimations for convincing market growth. Download PDF Sample of this Report @ https://www.reporthive.com/enquiry.php?id=1510050&req_type=smpl&utm_source=SN Key Players including: • Daimler (Germany) • BMW (Germany) • Tesla (US) • Audi (Germany) • Robert Bosch (Germany) • Continental (Germany) • Denso (Japan) • Delphi (UK) This 108 pages of report focuses on
Global Contrast Sensor Market 2025 | BALLUFF(Germany), CONTRINEX(Swizerland), Di …
Researchmoz added Most up-to-date research on "Global Contrast Sensor Market Insights, Forecast to 2025" to its huge collection of research reports. The Contrast Sensor market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the
Laparoscopic Electrodes Market - Aesculap (Germany), Angiodynamics (USA), Bovie …
Global Laparoscopic Electrodes Market Size, Status and Forecast 2022 provides Market information about Manufacturers, Countries, Type and Application.This Industry report also states Company Profile, sales, Laparoscopic Electrodes Market revenue and price, market share, market growth and gross margin by regions. Top Manufacturers/Key Players: Aesculap (Germany) Angiodynamics (USA) Bovie Medical (USA) BOWA-electronic (Germany) Erbe Elektromedizin GmbH (Germany) Ethicon Endo Surgery (USA) Gunter Bissinger Medizintechnik (Germany) HEBUmedical (Germany) Lagis Endosurgical (China Taiwan) LaproSurge (UK) Maxer Endoscopy (Germany) Mediflex Surgical Products (USA) Megadyne (Italy) MetroMed Healthcare (China